Cargando…
Adiponectin and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies
Background: Adiponectin has been suggested as a marker of many cardiovascular diseases. However, the association between serum adiponectin and incidence of atrial fibrillation (AF) in general population remains unclear. A meta-analysis was performed to systematically evaluate the potential influence...
Autores principales: | Guo, Ying, Liu, Lixin, Wang, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558722/ https://www.ncbi.nlm.nih.gov/pubmed/31088901 http://dx.doi.org/10.1042/BSR20182284 |
Ejemplares similares
-
Chronic Kidney Disease and the Risk of New-Onset Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies
por: Shang, Weifeng, et al.
Publicado: (2016) -
Association between adiponectin‐to‐leptin ratio and heart rate variability in new‐onset paroxysmal atrial fibrillation: A retrospective cohort study
por: Zhu, Tongjian, et al.
Publicado: (2021) -
The Association of New-Onset Atrial Fibrillation and Risk of Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Mengxia, et al.
Publicado: (2020) -
Lipid levels and risk of new‐onset atrial fibrillation: A systematic review and dose‐response meta‐analysis
por: Yao, Yisong, et al.
Publicado: (2020) -
Risk of New-Onset Atrial Fibrillation Post-cavotricuspid Isthmus Ablation in Typical Atrial Flutter Without History of Atrial Fibrillation
por: Li, Jia-hui, et al.
Publicado: (2021)